Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency - Menache, D; O’Malley, J P; Schorr, J B; Wagner, B; Williams, C (Blood, 1990)